Transcriptional coactivator MED15 is required for beta cell maturation

Alex Z Kadhim,Ben Vanderkruk,Samantha Mar,Meixia Dan,Katarina Zosel,Eric E Xu,Rachel J Spencer,Shugo Sasaki,Xuanjin Cheng,Shannon L J Sproul,Thilo Speckmann,Cuilan Nian,Robyn Cullen,Rocky Shi,Dan S Luciani,Bradford G Hoffman,Stefan Taubert,Francis C Lynn
DOI: https://doi.org/10.1038/s41467-024-52801-9
2024-10-08
Abstract:Mediator, a co-regulator complex required for RNA Polymerase II activity, interacts with tissue-specific transcription factors to regulate development and maintain homeostasis. We observe reduced Mediator subunit MED15 expression in endocrine hormone-producing pancreatic islets isolated from people living with type 2 diabetes and sought to understand how MED15 and Mediator control gene expression programs important for the function of insulin-producing β-cells. Here we show that Med15 is expressed during mouse β-cell development and maturation. Knockout of Med15 in mouse β-cells causes defects in β-cell maturation without affecting β-cell mass or insulin expression. ChIP-seq and co-immunoprecipitation analyses found that Med15 binds β-cell transcription factors Nkx6-1 and NeuroD1 to regulate key β-cell maturation genes. In support of a conserved role during human development, human embryonic stem cell-derived β-like cells, genetically engineered to express high levels of MED15, express increased levels of maturation markers. We provide evidence of a conserved role for Mediator in β-cell maturation and demonstrate an additional layer of control that tunes β-cell transcription factor function.
What problem does this paper attempt to address?